PROVO, Utah, Aug. 4, 2022 /PRNewswire/ — Nu Skin Enterprises, Inc. (NYSE: NUS) today announced second quarter 2022 results. Executive Summary Q2 2022 vs. Prior-year Quarter Revenue: $560.6 million; (20)% (5)% FX impact or $(34.6) million Earnings Per Share (EPS): $0.67 or $0.77 excluding…
Related Articles
News
USANA Foundation Mobilizes Hundreds from the Community to Pack 3,000 Food Bags for Utah Families Affected by SNAP Cutbacks
November 6, 2025
UCBN
News, Syndication
Comments Off on USANA Foundation Mobilizes Hundreds from the Community to Pack 3,000 Food Bags for Utah Families Affected by SNAP Cutbacks
Community-wide effort addresses growing food insecurity among Utah children and families SALT LAKE CITY, Nov. 6, 2025 /PRNewswire/ — In a powerful response to growing food insecurity affecting Utah families and the recent federal SNAP […]
News
Biolexis Therapeutics Unlocks a New Frontier in GLP-1 Receptor Activation
March 14, 2025
UCBN
News, Syndication
Comments Off on Biolexis Therapeutics Unlocks a New Frontier in GLP-1 Receptor Activation
CryoEM Confirms a First-in-Class Allosteric Binding Mode, Validating MolecuLern™ AI-Driven Discovery LEHI, Utah, March 14, 2025 /PRNewswire/ — Biolexis Therapeutics has achieved a transformative milestone in metabolic drug discovery with the successful resolution of the […]
News
Halia Therapeutics Continued Support to Utah’s Industry Community Recognized by First Place at the Utah Business Innovation Awards
October 31, 2023
UCBN
News, Syndication
Comments Off on Halia Therapeutics Continued Support to Utah’s Industry Community Recognized by First Place at the Utah Business Innovation Awards
– Company announces the appointment of Dr. David Bearss, CEO of Halia Therapeutics, as a member of the Board of Directors at BioUtah LEHI, Utah, Oct. 31, 2023 /PRNewswire/ — Halia Therapeutics, a clinical-stage biopharmaceutical […]
